|
PAN3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.704700E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.304080E-03 |
| Normal-vs-Stage2 |
3.929600E-02 |
| Normal-vs-Stage3 |
1.927440E-01 |
| Normal-vs-Stage4 |
4.587600E-01 |
| Stage1-vs-Stage2 |
7.674000E-01 |
| Stage1-vs-Stage3 |
1.064240E-01 |
| Stage1-vs-Stage4 |
2.369800E-02 |
| Stage2-vs-Stage3 |
2.174600E-01 |
| Stage2-vs-Stage4 |
1.165350E-01 |
| Stage3-vs-Stage4 |
6.105400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.947920E-02 |
| Normal-vs-AfricanAmerican |
3.440700E-03 |
| Normal-vs-Asian |
3.63130000000655E-05 |
| Caucasian-vs-AfricanAmerican |
1.170580E-01 |
| Caucasian-vs-Asian |
1.084320E-02 |
| AfricanAmerican-vs-Asian |
5.156400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.073700E-02 |
| Normal-vs-Female |
2.599100E-03 |
| Male-vs-Female |
3.220800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.753000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.164600E-04 |
| Normal-vs-Age(61-80Yrs) |
1.171170E-01 |
| Normal-vs-Age(81-100Yrs) |
8.209400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.780000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.979200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.895000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.324370E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.527580E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.088400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.03430000020622E-07 |
| Normal-vs-Grade 2 |
1.220290E-04 |
| Normal-vs-Grade 3 |
9.423800E-02 |
| Normal-vs-Grade 4 |
5.153400E-01 |
| Grade 1-vs-Grade 2 |
5.619700E-02 |
| Grade 1-vs-Grade 3 |
2.160300E-04 |
| Grade 1-vs-Grade 4 |
2.24839999996007E-06 |
| Grade 2-vs-Grade 3 |
6.659400E-03 |
| Grade 2-vs-Grade 4 |
3.60340000000736E-05 |
| Grade 3-vs-Grade 4 |
3.003800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.17460000000647E-05 |
| Normal-vs-ccB subtype |
3.376400E-01 |
| ccA subtype-vs-ccB subtype |
1.421040E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.639000E-03 |
| Normal-vs-N1 |
5.976600E-01 |
| N0-vs-N1 |
1.660160E-01 |
|
|
